A carregar...
Immunotherapy “Shock” a case series of PD-L1 100% and pembrolizumab first-line treatment
In this decade a “bloom” of novel therapies has been observed for non-small cell lung cancer. We have new tools for the diagnosis of lung cancer and also we can re-biospy easier than before in different lesions and obtain tissue samples in order to investigate whether a patient can receive new targe...
Na minha lista:
| Publicado no: | Respir Med Case Rep |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5576975/ https://ncbi.nlm.nih.gov/pubmed/28879076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2017.08.017 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|